Whistleblower accuses FDA of ‘relaxing review standards’…

US – Federal: The US Office of Special Counsel (OSC) has written to the president and Congress advising them that the US Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) had “relaxed its standards of review for certain tobacco products”. A CTP toxicologist-turned-whistleblower disclosed that a 2019 memo to CTP scientists on how to evaluate potentially harmful ingredients in substantial equivalence applications directed » Continue Reading. ...